Development of a decision tree to assess the severity and prognosis of stable COPD

European Respiratory Journal

Volumn 38, Issue 6, 2011, Pages 1294-1300

  Esteban, C ^a   Arostegui, I ^a   Moraza, J ^a   Aburto, M ^a   Quintana, J M ^b   Perez Izquierdo J ^a   Aizpiri, S ^a   Capelastegui, A ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Decision trees; Severity score

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLASSIFICATION AND REGRESSION TREE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MORTALITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DECISION TREES; DISEASE PROGRESSION; DYSPNEA; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK; SEVERITY OF ILLNESS INDEX;

EID: 82555194446     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00189010     Document Type: Article

References (30)

1. Celli BC, Cote CG, Marín JM, et al. The body-mass index, airflow obstruction, dyspnoea, and exercise capacity index in chronic obstructive pulmonary disease. New Engl JMed 2004; 350: 1005-1012. (Pubitemid 38269277)
2. Esteban C, Quintana JM, Aburto M, et al. A simple score for assessing stable chronic obstructive pulmonary disease. QJM 2006; 99: 751-759. (Pubitemid 44688409)
3. Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374: 704-711.
4. Soler-Cataluña JJ, Martínez-García MA, Sánchez LS, et al. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med 2009; 103: 692-699.
5. Zhang H, Singer B. Recursive Partitioning in the Health Sciences, New York, Springer-Verlag, 1999.
6. Santos M, Braga JU, Gomes RV, et al. Predictive factors for pneumonia onset after cardiac surgery in Rio de Janeiro, Brazil. Infect Control Hosp Epidemiol 2007; 28: 382-388. (Pubitemid 46658049)
7. Hansell AL, Lam KA, Richardson S, et al. Medical event profiling of COPD patients. Pharmacoepidemiol Drug Saf 2004; 13: 547-555. (Pubitemid 39214033)
8. Fletcher CM, Elmes PC, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ 1959; 2: 257-266.
9. Sanchis J. Normativa para la espirometría forzada: Grupo de trabajo de la SEPAR para la práctica de la espirometría clínica. [Guidelines for spirometry]. Arch Bronconeumol 1989; 25: 132-142.
10. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function test, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 1993; 16: Suppl. 16, 5-40.
11. American Thoracic Society. Standardization of spirometry: 1994 update. Am Rev Respir Dis 1994; 152: 1107-1136.
12. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61: 772-778. (Pubitemid 44369401)
13. Schnohr P, Scharling H, Jensen JS. Changes in leisure time physical activity and risk of death: an observational study of 7000 men and females. Am J Epidemiol 2003; 158: 639-644. (Pubitemid 37175511)
14. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the sixminute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
15. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85: 25-31.
16. Ferrer M, Alonso J, Prieto L, et al. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J 1996; 9: 1160-1166. (Pubitemid 26231729)
17. Hosmer DH, Lemeshow S. Applied Logistic Regression, 2nd Edn. New York: Wiley and Sons, 2000.
18. SAS Institute Inc. SAS Procedures Guide, Version 6. Cary: SAS Institute, 1994.
19. R development Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing, 2005.
20. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 14-20. (Pubitemid 16189089)
21. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15 year follow up study. Am Rev Respir Dis 1979; 119: 895-902. (Pubitemid 9208242)
22. Esteban C, Quintana JM, Aburto M, et al. Predictors of mortality in patients with stable COPD. J Gen Intern Med 2008; 23: 1829-1834.
23. Nishimura K, Takateru I, Tsukino M, et al. Dyspnoea is a better predictor of 5 year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440. (Pubitemid 34499652)
24. Celli BR, MacNee W, Agusti A, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946. (Pubitemid 38807371)
25. Soler-Cataluña JJ, Martinez-Garcia MA, Román Sánchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931. (Pubitemid 41598207)
26. Gale RP, Park RE, Dubois RW, et al. Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplant in chronic myelogenous leukemia in chronic phase. Leuk Res 1999; 23: 817-826. (Pubitemid 29341472)
27. Wietlisbach V, Vader JP, Porchet F, et al. Statistical approaches in the development of clinical practice guidelines from expert panels. Medical Care 1999; 37: 785-797.
28. McConnochie KM, Roghmann KJ, Pasternack J. Developing prediction rules and evaluating observation patterns using categorical clinical markers: two complementary procedures. Med Decis Making 1993; 13: 30-42. (Pubitemid 23019917)
29. Soriano JB, Ancochea J, Miravitlles M, et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur Respir J 2010; 36: 758-765.
30. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation and Updating. New York, Springer-Verlag, 2009.